Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation

Blood

Volumn 95, Issue 11, 2000, Pages 3302-3309

  Price, Thomas H ^a   Bowden, Raleigh A ^b   Boeckh, Michael ^b   Bux, Juergen ^b   Nelson, Karen ^b   Liles, W Conrad ^b   Dale, David C ^b  

^a PUGET SOUND BLOOD CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; BONE PAIN; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION; MALE; NEUTROPENIA; NEUTROPHIL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TRANSFUSION;

EID: 0034210228     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3302     Document Type: Article

References (43)

1. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993;328:1323.
2. Hughes WT, Armstrong D, Bodey GP, et al. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis. 1997;25:551.
3. Engels EA, Ellis CA, Supran SE, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis. 1999;28:256.
4. Klein HG, Strauss RG, Schiffer CA. Granulocyte transfusion therapy. Semin Hematol. 1996; 33:359.
5. Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997;98:497.
6. Strauss RG. Therapeutic granulocyte transfusions in 1993. Blood. 1993;81:1675.
7. Boggs DR. Transfusion of neutrophils as prevention or treatment of infection in patients with neutropenia. N Engl J Med. 1974;290:1055.
8. Appelbaum FR, Bowles CA, Makuch RW, Deisseroth AB. Granulocyte transfusion therapy of experimental Pseudomonas septicemia: study of cell dose and collection technique Blood. 1978; 52:323.
9. Cairo MS, Worcester C, Rucker RW, et al. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr. 1992;120:281.
10. Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G-CSF) and dexamethasone. Transfusion. 1998;38:713.
11. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood. 1993;81:1883.
12. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996;88:335.
13. Bux J, Stein EL, Bierling P, et al. Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb. Blood. 1997;89:1027.
14. Press C, Kline WE, Clay ME, McCullough J. A microtiter modification of granulocyte immunofluorescence. Vox Sang. 1985;49:110.
15. McCullough J, Clay M, Press C, Kline W. Granulocyte Serology: A Clinical and Laboratory Guide. Chicago: ASCP Press; 1988.
16. Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC. A comparative trial of granulocyte-colony-stimulating factor and dexamethasone, separately and in combination, for the mobilization of neutrophils in the peripheral blood of normal volunteers. Transfusion. 1997;37:182.
17. Graw RG, Herzig GH, Perry S, Henderson ES. Normal granulocyte transfusion therapy: treatment of septicemia due to gram-negative bacteria. N Engl J Med. 1972;287:367.
18. Herzig RH, Herzig GP, Graw RG, Bull MI, Ray KK. Successful granulocyte transfusion therapy for gram-negative septicemia: a prospectively randomized controlled study. N Engl J Med. 1977; 296:701.
19. Higby DJ, Yates JW, Henderson ES, Holland JF. Filtration leukapheresis for granulocyte transfusion therapy: clinical and laboratory studies. N Engl J Med. 1975;292:761.
20. Alavi JB, Root RK, Djerassi I, et al. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med. 1977;296: 706.
21. Vogler WR, Winton EF. Controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med. 1977;63:548.
22. Winston DJ, Ho WG, Gale RP. Therapeutic granulocyte transfusions for documented infections: a controlled trial in ninety-five infectious granulocytopenic episodes. Ann Intern Med. 1982;97:509.
23. Schiffer C. Granulocyte transfusions: an overlooked therapeutic modality. Trans Med Rev 1990;4:2.
24. Fetscher S, Mertelsmann R. Supportive care in hematologic malignancies. Curr Opin Hematol. 1998;5:271.
25. Price TH. Granulocyte colony-stimulating factor-mobilized granulocyte concentrate transfusions. Curr Opin Hematol. 1998;5:391.
26. Vamvakas EC, Pineda AA. Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis. J Clin Apheresis. 1996;11:1.
27. Grigg A, Vecchi L, Bardy P, Szer J. G-CSF stimulated donor granulocyte collections for prophylaxis and therapy of neutropenic sepsis. Aust N Z J Med. 1996;26:813.
28. Hester JP, Dignani MC, Anaissie EJ, Kantarjian HM, O'Brien S, Freireich EJ. Collection and transfusion of granulocyte concentrates from donors primed with granulocyte stimulating factor and response of myelosuppressed patients with established infection. J Clin Apheresis. 1995;10:188.
29. Leitman SF, Oblitas JM, Emmons R, Dunn DE, Young NS. Clinical efficacy of daily G-CSF-recruited granulocyte transfusions in patients with severe neutropenia and life-threatening infections [abstract]. Blood. 1996;88(suppl 1):331A.
30. Adkins D, Goodgold H, Hendershott L, Johnston M, Cravens D, Spitzer G. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1997;19:809.
31. Schiffer C, Aisner J, Daly P, Schimpff S, Wiernik P. Alloimmunization following prophylactic granulocyte transfusion. Blood. 1979;54:766.
32. Stroncek DF. Neutrophil antibodies. Curr Opin Hematol. 1997;4:455.
33. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood. Br J Haematol. 1996;93:707.
34. Bow EJ, Schroeder ML, Louie TJ. Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B. Can Med Assoc J. 1984;130:593.
35. Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981;304:1185.
36. Dignani MC, Anaissie EJ, Hester JP, et al. Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study. Leukemia. 1997;11:1621.
37. Di Mario A, Sica S, Salutari P, La Barbera EO, Marra R, Leone G. Granulocyte colony-stimulating factor-primed leukocyte transfusions in Candida tropicalis fungemia in neutropenic patients. Haematologica. 1997;82:362.
38. Catalano L, Fontana R, Scarpato N, Picardi M, Rocco S, Rotoli B. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation. Haematologica. 1997;82:71.
39. Anderlini P, Przepiorka D, Korbling M, Champlin R. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant Supp, 1998;3:S35.
40. Cheers C, Haigh AM, Kelso A, Metcalf D, Stanley ER, Young AM. Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-macrophage-, and multi-CSFs. Infect Immun. 1988; 56:247.
41. Kawakami M, Tsutsumi H, Kumakawa T, et al. Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood. 1990; 76:1962.
42. Dale DC, Lau S, Nash R, Boone T, Osborne W. Effect of endotoxin on serum granulocyte and granulocyte-macrophage colony-stimulating factor levels in dogs. J Infect Dis. 1992;165:689.
43. Taveira da Silva AM, Kaulbach HC, Chuidian FS, Lambert DR, Suffredini AF, Danner RL. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med. 1993;326:1457.